Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Supernus Pharmaceuticals Raises FY20 Sales Guidance From $460M-$500M To $500M-$525M Vs. $486.54M Est


Benzinga | Nov 3, 2020 04:34PM EST

Supernus Pharmaceuticals Raises FY20 Sales Guidance From $460M-$500M To $500M-$525M Vs. $486.54M Est






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC